Raphas Co., Ltd. Logo

Raphas Co., Ltd.

Develops and manufactures dissolving microneedle patches for drug delivery.

214260 | KO

Overview

Corporate Details

ISIN(s):
KR7214260002
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로1길 62 라파스, 강서구

Description

Raphas Co., Ltd. is a biotechnology company specializing in advanced drug delivery systems. The company develops and manufactures biodegradable, dissolving microneedles using its proprietary DEN technology, a transdermal delivery platform. This technology is applied to create patches for a range of cosmetic and therapeutic needs, including anti-aging, wrinkle reduction, whitening, and acne treatment. Raphas commercializes its products through its own cosmetics brand, Acropass, and also offers manufacturing services for custom patch development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2021-11-19 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 113.0 KB
2021-11-12 00:00
분기보고서 (2021.09)
Korean HTML 1.4 MB
2021-11-01 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 23.6 KB
2021-10-19 00:00
투자판단관련주요경영사항(알레르기비염 면역치료제 DF19001의 임상 1상 임상시험계획승인)
Korean HTML 10.0 KB
2021-10-18 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean HTML 5.8 KB
2021-10-13 00:00
기업설명회(IR)개최
Korean HTML 7.2 KB
2021-10-13 00:00
[기재정정]타법인주식및출자증권취득결정(자율공시)
Korean HTML 18.3 KB
2021-10-12 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 62.7 KB
2021-10-05 00:00
타법인주식및출자증권취득결정(자율공시)
Korean HTML 15.2 KB
2021-09-14 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 118.2 KB
2021-09-09 00:00
기타경영사항(특허권취득)(자율공시)(마이크로니들-파티클의 제조방법, 이러한 제조방법에 의해 제조된 마이크로니들-파티클 및 이러한 마이크로니들-…
Korean HTML 5.3 KB
2021-09-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 26.0 KB
2021-08-30 00:00
기타경영사항(특허권취득)(자율공시)(레티놀 안정화를 위한 사이클로덱스트린을 포함하는 마이크로니들 제조용 조성물 및 이러한 조성물로 제조된 마이…
Korean HTML 5.0 KB
2021-08-23 00:00
증권발행결과(자율공시)
Korean HTML 5.6 KB
2021-08-19 00:00
주요사항보고서(전환사채권발행결정)
Korean HTML 62.6 KB

Automate Your Workflow. Get a real-time feed of all Raphas Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Raphas Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Raphas Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.